Search results
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 6 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Reuters via Yahoo Finance· 6 days agoMerck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's top selling ...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 5 days agoThe adjustment comes in the wake of Merck's first-quarter results, which not only featured a robust...
Man’s ‘bump on head’ turns out to be sign of skin cancer
Yahoo Life UK· 5 days agoYoung, who had the melanoma growth cut out of his scalp last August, is one of the first patients to...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 6 days agoThe Zacks Consensus Estimate for 2024 EPS has declined from $11.13 per share to $11.12 over the past...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 7 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Bristol-Myers stock falls despite Q1 beat (NYSE:BMY)
Seeking Alpha· 6 days agoBristol-Myers Squibb (BMY) stock dips even as the company topped consensus with Q1 2024 results, despite headwinds in its growth portfolio. Read more...
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 5 days agoUniversity College London Hospitals (UCLH) doctors are giving it alongside another drug,...
British patients test world’s first personalised mRNA jab for melanoma
PA Media: Science via Yahoo News· 5 days agoPhase 2 data, published in December, found that people with serious high-risk melanomas who received...
Merck stock rises on sales of its blockbuster cancer drug Keytruda
Quartz· 6 days agoMerck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than expected sales of its blockbuster cancer drug < ...